{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:38:33Z","timestamp":1790735913625,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.euroneuro.2014.12.013","type":"journal-article","created":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T11:54:19Z","timestamp":1420458859000},"page":"864-872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["IGF-I in major depression and antidepressant treatment response"],"prefix":"10.1016","volume":"25","author":[{"given":"Anna","family":"Kopczak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter Karl","family":"Stalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Uhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Lucae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Hennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Ising","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Holsboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kloiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2014.12.013_bib1","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1212\/WNL.0b013e3182752eef","article-title":"Insulin-like growth factors in the brain and their potential clinical implications","volume":"79","author":"Benarroch","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib2","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng1479","article-title":"Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment","volume":"36","author":"Binder","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.euroneuro.2014.12.013_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000328226","article-title":"The corticotropin-releasing hormone network and the hypothalamic\u2013pituitary\u2013adrenal axis: molecular and cellular mechanisms involved","volume":"94","author":"Bonfiglio","year":"2011","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/0891988713495449","article-title":"The stress response to surgery and postoperative delirium: evidence of hypothalamic\u2013pituitary\u2013adrenal axis hyperresponsiveness and decreased suppression of the GH\/IGF-1 axis","volume":"26","author":"Cerejeira","year":"2013","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.euroneuro.2014.12.013_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1373\/clinchem.2010.150631","article-title":"Consensus statement on the standardization and evaluation of growth hormone und insulin-like growth factor assays","volume":"57","author":"Clemmons","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.euroneuro.2014.12.013_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0306-4530(97)00046-2","article-title":"Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients","volume":"22","author":"Deuschle","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ghir.2009.09.004","article-title":"The current status of IGF-I assays\u2014a 2009 update","volume":"20","author":"Frystyk","year":"2010","journal-title":"Growth Horm. IGF Res"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1176\/appi.ajp.2012.12020237","article-title":"Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies","volume":"170","author":"GENDEP Investigators; MARS Investigators; STAR\u204eD Investigators","year":"2013","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.euroneuro.2014.12.013_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jpsychires.2008.05.002","article-title":"Clinical characteristics and treatment outcome in a representative sample of depressed inpatients\u2014findings from the Munich Antidepressant Response Signature (MARS) project","volume":"43","author":"Hennings","year":"2009","journal-title":"J. Psychiatr Res."},{"key":"10.1016\/j.euroneuro.2014.12.013_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000103573","article-title":"Changes in the hypothalamic\u2013pituitary\u2013adrenal axis and leptin levels during antidepressant treatment","volume":"55","author":"Himmerich","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/edrv-17-2-187","article-title":"Antidepressants and hypothalamic\u2013pituitary\u2013adrenocortical regulation","volume":"17","author":"Holsboer","year":"1996","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.euroneuro.2014.12.013_bib12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","article-title":"The corticosteroid receptor hypothesis of depression","volume":"23","author":"Holsboer","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/npp.2009.180","article-title":"Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment","volume":"35","author":"Horstmann","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.biopsych.2006.07.039","article-title":"Combined dexamethasone\/corticotropin releasing hormone test predicts treatment response in major depression\u2014a potential biomarker?","volume":"62","author":"Ising","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib15","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1210\/endo.139.7.6099","article-title":"Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes","volume":"139","author":"Jux","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuron.2011.04.005","article-title":"The neuronal transporter gene SLC6A15 confers risk to major depression","volume":"70","author":"Kohli","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib17","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1600-0447.1988.tb06404.x","article-title":"Insulin-like growth factor I in depressed patients and controls","volume":"78","author":"Lesch","year":"1988","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2014.12.013_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1055\/s-2008-1058076","article-title":"Growth hormone inhibits the 11 beta-hydroxysteroid dehydrogenase type 1 gene promoter activity via insulin-like growth factor I in HepG2 cells","volume":"40","author":"Li","year":"2008","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.euroneuro.2014.12.013_bib19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/mp.2012.21","article-title":"A mega-analysis of genome-wide association studies for major depressive disorder","volume":"18","author":"Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib20","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1210\/endo-126-3-1569","article-title":"Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells","volume":"126","author":"McCarthy","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4088\/JCP.v61n0204","article-title":"Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group","volume":"61","author":"Mehtonen","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib22","first-page":"4172","article-title":"Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies","volume":"84","author":"Moore","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2014.12.013_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000321243","article-title":"Modulation of glucocorticoid metabolism by the GH-IGF-I axis","volume":"20","author":"Neggers","year":"2011","journal-title":"Endocr. Dev"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib24","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1210\/endo.135.5.7525251","article-title":"Insulin-like growth factors cross the blood\u2013brain barrier","volume":"135","author":"Reinhardt","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-0327(89)90018-9","article-title":"Effects of glucocorticoids on the regulation of the hypothalamic\u2013pituitary\u2013somatotropic system in depression","volume":"17","author":"Rupprecht","year":"1989","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2014.12.013_bib26","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/JCP.0b013e3182189d86","article-title":"Treatment with antidepressants increases insulin-like growth factor-I in cerebrospinal fluid","volume":"31","author":"Schilling","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.12.013_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2741\/2662","article-title":"Insulin-like growth factor-1 in plasma and brain: regulation in health and disease","volume":"13","author":"Sievers","year":"2008","journal-title":"Front Biosci."},{"key":"10.1016\/j.euroneuro.2014.12.013_bib29","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.euroneuro.2014.01.008","article-title":"IGF-I levels and depressive disorders: results from the Study of Health in Pomerania (SHIP)","volume":"24","author":"Sievers","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.12.013_bib30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/dneu.20778","article-title":"Toward a comprehensive neurobiology of IGF-I","volume":"70","author":"Torres-Aleman","year":"2010","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.euroneuro.2014.12.013_bib31","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1210\/endo.133.6.7694841","article-title":"Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat","volume":"133","author":"Unterman","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/gepi.21766","article-title":"A robust method for genome-wide association meta-analysis with the application to circulating insulin-like growth factor I concentrations","volume":"38","author":"Wang","year":"2014","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.euroneuro.2014.12.013_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-0028-1085442","article-title":"Insulin-like growth factor-I (IGF-I) serum concentrations in depressed patients: relationship to saliva cortisol and changes during antidepressant treatment","volume":"42","author":"Weber-Hamann","year":"2009","journal-title":"Pharmacopsychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.euroneuro.2014.12.013_bib34","first-page":"37","article-title":"The role of the insulin-like growth factor system in the developing brain","volume":"49","author":"Werther","year":"1998","journal-title":"Horm. Res"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib35","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4088\/JCP.09m05650blu","article-title":"Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project","volume":"71","author":"Wiethoff","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1749-6632.2009.04980.x","article-title":"Glucocorticoids. Mood, memory, and mechanisms","volume":"1179","author":"Wolkowitz","year":"2009","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"10.1016\/j.euroneuro.2014.12.013_bib37","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/archpsyc.1991.01810320017003","article-title":"Loss of glucocorticoid fast feedback in depression","volume":"48","author":"Young","year":"1991","journal-title":"Arch Gen Psychiatry."},{"key":"10.1016\/j.euroneuro.2014.12.013_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3956(01)00013-9","article-title":"Cortisol response in the combined dexamethasone\/CRH test as predictor of relapse in patients with remitted depression. a prospective study","volume":"35","author":"Zobel","year":"2001","journal-title":"J. Psychiatr Res."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14003605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14003605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:53:00Z","timestamp":1760377980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X14003605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0924977X14003605"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.12.013","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IGF-I in major depression and antidepressant treatment response","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}